£76.61

It has never been this cheap. We have no record of a lower price.

£77 today · cheaper than every other day in the last 3 months

Updates on Molecular Targeted Therapies for CNS Tumors

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 51 days · 51 data points (no recent data)

Historical
Generating forecast…
£76.62 £76.61 £76.61 £76.61 £76.62 £76.62 £76.62 25 July 2026 06 August 2026 19 August 2026 31 August 2026 13 September 2026
View at Amazon ↗

Price data last checked 40 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 51 days • 1 price levels

Days at Price
51 days 0 13 26 38 51 £77 Days at Price

Price Analysis

Most common price: £77 (51 days, 100.0%)

Price range: £77 - £77

Price levels: 1 different prices over 51 days

Description

The challenges in identifying effective therapies for CNS tumors continue to be daunting. Potentially effective targeted therapies must be able to penetrate the blood-brain barrier to reach the tumor and, in sufficient concentrations, to result in meaningful treatment responses. Moreover, molecular targets must be key drivers in the growth and progression of CNS tumors. Numerous potentially efficacious therapies have failed in randomized clinical trials due to other factors, including subclonal genetic intratumoral heterogeneity (particularly within malignant gliomas), epigenetic heterogeneity, and failure to target important factors involved in the tumor microenvironment. Developing effective targeted therapies requires a thorough fundamental understanding of the genetic and epigenetic factors driving tumor progression, the interactions between CNS tumor cells and the tumor microenvironment, and the key mechanisms of tumor treatment resistance. In this Special Issue, experts in the field of CNS tumors will highlight the most promising molecular targets in the development of treatments for patients with CNS tumors.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
23 August 2023
Listed Since
24 August 2023

Barcode

No barcode data available

Similar Products You Might Like

Updates on Imaging of Common Urogenital Neoplasms
99% match

Updates on Imaging of Common Urogenital Neoplasms

£64.61 25 Sep 2026
PET/CT Imaging in Oncology: Clinical Updates and Perspectives
99% match

PET/CT Imaging in Oncology: Clinical Updates and Perspectives

£51.92 03 Oct 2026
Updates on Breast Cancer
99% match

Updates on Breast Cancer

£79.63 22 Sep 2026
Molecular Biomarkers of Tumors: Advancing Genetic Studies
98% match

Molecular Biomarkers of Tumors: Advancing Genetic Studies

£65.74 12 Sep 2026
Delivery of Molecules Using Nanoscale Systems for Cancer Treatment and/or Diagnosis
98% match

Delivery of Molecules Using Nanoscale Systems for Cancer Treatment and/or Diagnosis

£63.16 25 Sep 2026
Redox Active Molecules in Cancer Treatments
98% match

Redox Active Molecules in Cancer Treatments

£64.26 18 Sep 2026
Genetic and Epigenetic Regulations of Tumor Progression and Metastasis
98% match

Genetic and Epigenetic Regulations of Tumor Progression and Metastasis

£58.08 18 Sep 2026
Immunotherapy, Tumor Microenvironment and Survival Signaling
98% match

Immunotherapy, Tumor Microenvironment and Survival Signaling

£68.58 18 Sep 2026
Biomarkers of Tumor Metastasis and Invasiveness
98% match

Biomarkers of Tumor Metastasis and Invasiveness

£71.62 17 Sep 2026
Cancer Prevention with Molecular Target Therapies
98% match

Cancer Prevention with Molecular Target Therapies

£58.09 11 Sep 2026
Metabolic Alterations in Cancer
98% match

Metabolic Alterations in Cancer

£59.18 10 Sep 2026
Molecules at Play in Cancer
98% match

Molecules at Play in Cancer

£76.61 18 Sep 2026
Tumor Immunology and Immunotherapy Resistance
98% match

Tumor Immunology and Immunotherapy Resistance

£58.09 12 Sep 2026
Chronic Pain: Clinical Updates and Perspectives
98% match

Chronic Pain: Clinical Updates and Perspectives

£58.09 10 Sep 2026
Advances in Cancer Data and Statistics
98% match

Advances in Cancer Data and Statistics

£70.69 12 Sep 2026
Molecules at Play in Neurological Diseases
98% match

Molecules at Play in Neurological Diseases

£62.07 27 Sep 2026
Natural Products in Photodynamic Therapy
98% match

Natural Products in Photodynamic Therapy

£54.18 23 Sep 2026
Redox-Active Molecules as Therapeutic Agents
98% match

Redox-Active Molecules as Therapeutic Agents

£57.68 27 Sep 2026
Recent Advances in Deep Learning and Medical Imaging for Cancer Treatment
98% match

Recent Advances in Deep Learning and Medical Imaging for Cancer Treatment

£96.01 23 Sep 2026
Advances in Chromatographic Analysis of Bioactive Compounds
98% match

Advances in Chromatographic Analysis of Bioactive Compounds

£68.61 23 Sep 2026
Angiogenesis in Cancers
98% match

Angiogenesis in Cancers

£64.26 11 Sep 2026
Advances in Soft Tissue and Bone Sarcoma
98% match

Advances in Soft Tissue and Bone Sarcoma

£58.69 12 Sep 2026
Advanced Clinical Technologies in Treating Neurosurgical Diseases
98% match

Advanced Clinical Technologies in Treating Neurosurgical Diseases

£62.49 03 Oct 2026
Diagnosis and Treatment for Hepatocellular Tumors
98% match

Diagnosis and Treatment for Hepatocellular Tumors

£70.42 18 Sep 2026